Drug Costs: Control at Price of Research?

By Caprino, Mariann | THE JOURNAL RECORD, April 1, 1993 | Go to article overview

Drug Costs: Control at Price of Research?


Caprino, Mariann, THE JOURNAL RECORD


By Mariann Caprino

Associated Press

NEW YORK _ One of the drug industry's favorite arguments against lower prices is the possibility that money would be deprived from research critical to developing lifesaving medicines.

Experience in countries where drug prices are regulated shows pharmaceutical makers are right _ up to a point.

"Simple observation would show that there is little pharmaceutical research undertaken in nations having the lowest pharmaceutical prices," said Albert Wertheimer, dean of the Philadelphia College of Pharmacy and Science's School of Pharmacy.

Take Australia, where 90 percent of all prescriptions are regulated. Drugs cost 55 percent of average world prices in 1987.

But one result, Wertheimer said, is that "with virtually no incentive to develop new drugs, the pharmaceutical industry there produces few new medications."

The U.S. drug industry, one of the most profitable businesses in the world, is a key target of the Clinton administration as it grapples with taming the nation's spiraling medical bills.

The industry's drug prices have been deeply criticized as a symbol of heartless greed. Several lawmakers have called for price restraints to be included in the health care reform package the administration is shaping.

Drug makers have suggested that such restraints would obstruct the pipeline of new drugs.

"What's important is to find some happy medium that makes drugs available at affordable prices but does not stymie the efforts of an extremely successful industry," said Dr. Alan L. Hillman, director of the Center for Health Policy at the University of Pennsylvania's Leonard Davis Institute.

It might feel like walking a tightrope, but experience in England, France and Germany shows it is possible to lower drug prices without harming the industry, he said.

In Britain, for example, home of drug giants Glaxo, SmithKline Beecham and Wellcome, the government allows companies with more innovative products to keep more of the profits.

France, with stiff regulations on the drug industry, is home to a number of successful, large drug companies like Rhone-Poulenc. Drug makers there are required to show a new drug will save costly medical treatments down the road in order to justify the price.

U.S. drug makers already know how to operate in regulated markets; about 45 percent of their sales are derived overseas. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Drug Costs: Control at Price of Research?
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.